Substance misuse in patients with schizophrenia: a primary care guide
Related Experiment Video
Updated: Sep 26, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
1Orygen Research Centre, Cognitive Neuropsychiatry Research and Academic Unit, University of Melbourne, VIC. dan.lubman@mh.org.au
Abstract:
Smoking presents a substantial health and economic burden to people with schizophrenia. Comorbid use of other substances is common, under-recognised, and associated with a number of serious adverse consequences, such as psychotic relapse and poorer social outcomes. All patients with schizophrenia need to be screened for substance misuse. Effective interventions involve integrated, modified pharmacological and psychosocial strategies.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
